Neuregulin-1 and ALS19 (ERBB4): at the crossroads of amyotrophic lateral sclerosis and cancer.

Jacob J AdashekChinmayi PandyaNicholas J MaragakisPradip DePhilip R CohenShumei KatoRazelle Kurzrock

Published in: BMC medicine (2024)

Common signaling cascades between cancer and ALS may represent novel therapeutic targets for both diseases.

Keyphrases